5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost-Reference-Cited by-同舟云学术

5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost

Published:2019-10 Issue:2 Volume:105 Page:267-274
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Gupta Apar,Khan Atif J.,Yegya-Raman Nikhil,Sayan Mutlay,Ahlawat Stuti,Ohri Nisha,Goyal Sharad,Moore Dirk F.,Eladoumikdachi Firas,Toppmeyer Deborah,Haffty Bruce G.

Funder

National Cancer Institute

Breast Cancer Research Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference38 articles.

1. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials;Haviland;Lancet Oncol,2013

2. Long-term results of hypofractionated radiation therapy for breast cancer;Whelan;N Engl J Med,2010

3. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial;Owen;Lancet Oncol,2006

4. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013;Bekelman;JAMA,2014

5. Cost-effectiveness analysis comparing conventional, hypofractionated, and intraoperative radiotherapy for early-stage breast cancer;Deshmukh;J Natl Cancer Inst,2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation-induced dermatitis among breast cancer patients undergoing adjuvant radiotherapy in Ghana;Translational Oncology;2024-08

2. Hypofractionated wholebreast irradiation with sequential or simultaneous integrated boost for early breast cancer after-surgery treatment;2024-04-19

3. Long-Term Clinical and Cosmetic Outcomes of Once-Daily Accelerated Partial Breast Irradiation in Early Breast Cancer;Advances in Radiation Oncology;2024-01

4. Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma;Cancers;2023-08-09

5. Tumor Bed Boost Radiotherapy in the Conservative Treatment of Breast Cancer: A Review of Intra-Operative Techniques and Outcomes;Cancers;2023-08-08